Skip to content
Tech News
← Back to articles

Weizmann-led study links histone modification patterns to breast cancer diagnosis

read original more articles
GoKawiil Brief

Researchers analyzed histone post-translational modifications in breast tumor tissue, blood plasma, and patient-derived xenograft models to characterize epigenetic variation within breast tumors. The work combined samples from institutions including the European Institute of Oncology, Mayo Clinic, Sheba Medical Center, and the Weizmann Institute of Science, using mass-spectrometry-based analysis and mouse models implanted with human tumor tissue.

Why It Matters

GoKawiil's interpretation of the reporting above, not reported fact.

Mapping how histone modifications vary across tumor cells could offer new biomarkers for distinguishing cancer subtypes or predicting disease progression, beyond standard genetic mutation analysis. If validated further, such epigenetic profiling might eventually support less invasive diagnostic or prognostic tools using blood plasma rather than tissue biopsies.

Key Takeaways

Source: nature.com — Furth, 2026-11-11

Published there as: “Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis”

Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.
Keep reading
breast cancer 7 briefs → mass spectrometry 4 briefs →